Atul Kumar
Overview
Explore the profile of Atul Kumar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
533
Citations
3818
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kumar A, Palle E, Kodali P, Thankappan K
BMC Health Serv Res
. 2025 Feb;
25(1):309.
PMID: 40001032
Background: Lack of trust in healthcare systems results in underutilization, non-adherence to medications, poor healthcare outcomes, and catastrophic health expenditure. Literature on people's trust on public health care system is...
2.
Mega P, de Moura E, Bestetti A, Ramai D, Kumar A, Hajjar L, et al.
Endoscopy
. 2025 Feb;
PMID: 39983768
Background And Study Aims: Endoscopic Vacuum Therapy (EVT) is a well-established method for managing gastrointestinal perforations. During the COVID epidemic, case reports demonstrated the effective use of EVT in controlling...
3.
Bose S, Sharma S, Kumar A, Mishra Y, Mishra V
Med Oncol
. 2025 Feb;
42(3):76.
PMID: 39960609
Ovarian cancer is the deadliest gynecological cancer, often being diagnosed at a late-stage when the disease is already advanced. This makes it known as the ''silent killer'' due to its...
4.
Salah E, Sontakke B, Hamoud A, Emadifar H, Kumar A
Sci Rep
. 2025 Jan;
15(1):3465.
PMID: 39870737
The main objective of this work is to study the mathematical model that combines stem cell therapy and chemotherapy for cancer cells. We study the model using the fractal fractional...
5.
Mishra S, Kumar P, Joshi A, Saraf A, Awasthi A, Dhar S, et al.
Int J Retina Vitreous
. 2025 Jan;
11(1):6.
PMID: 39806501
Background: Management of Diabetic Macular edema (DME) requires repeated injections. Therefore newer Anti-VEGFs like Brolucizumab with longer durability have been introduced. We compared two different dosages of Brolucizumab, 6.0 mg...
6.
Kohli M, Bansal H, Aski M, Mishra G, Shashidhar B, Roy A, et al.
Sci Rep
. 2024 Dec;
14(1):31805.
PMID: 39738266
The mungbean yellow mosaic India virus (MYMIV, Begomovirus vignaradiataindiaense) causes Yellow Mosaic Disease (YMD) in mungbean (Vigna radiata L.). The biochemical assays including total phenol content (TPC), total flavonoid content...
7.
Mishra U, Singh K, Kumar A, Singh V, Mishra D, Chandel V, et al.
Anal Methods
. 2024 Dec;
17(2):349-359.
PMID: 39633582
Herein, we report a label-free cancer biosensor designed for carcinoembryonic antigen (CEA) detection using a nanohybrid comprising CeO nanoparticles, carbon nanoparticles (CNPs), and chitosan (Ch). CeO nanoparticles were prepared using...
8.
Fernandes Gomes B, Kumar A, Ashton N, Hall S, Stomrud E, Smith R, et al.
Brain Commun
. 2024 Nov;
6(6):fcae414.
PMID: 39605973
Disease-specific fluid biomarkers are in demand for parkinsonian syndromes (PS). Corticotropin-releasing hormone (CRH) was proposed as a biomarker for Lewy body disease. As such, this project aimed to confirm CRH...
9.
Apoorva , Kumar A, Singh S
Tissue Barriers
. 2024 Nov;
:2424628.
PMID: 39508307
Dengue virus (DENV) infections are commonly reported in the tropical and subtropical regions of the world. DENV is reported to exploit various strategies to cross the blood-brain barrier. The NS1...
10.
Karim N, Miao J, Reckamp K, Gay C, Byers L, Zhao Y, et al.
J Thorac Oncol
. 2024 Nov;
20(3):383-394.
PMID: 39505259
Objective: To evaluate whether the addition of a poly (adenosine diphosphate-ribose) polymerase inhibitor talazoparib to maintenance immune checkpoint inhibitor atezolizumab after frontline chemoimmunotherapy improved outcomes in patients with Schlafen 11...